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Capsule Summary: 30 
The incidence of childhood eczema is approximately 14% in the first year of life and 31 
decreases substantially in later childhood; early onset is significantly associated with 32 
gender, ethnicity and socioeconomic status. 33 
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To the Editor: 34 
We report the results of a large population-based cohort study examining the incidence 35 
of clinically diagnosed eczema in children and the variations by sociodemographic 36 
characteristics. Eczema (also known as atopic eczema/dermatitis1) affects up to 1 in 5 37 
children2 and is associated with high morbidity.3  38 
There are limited estimates on the incidence of eczema and how the incidence varies by 39 
sociodemographic factors, which is important for generating hypotheses regarding the 40 
disease aetiology and for health service planning. To address this issue, we examined 41 
the incidence of eczema diagnosis in children aged 0-17 years between 1st April 1997 42 
and 31st March 2015 using the Clinical Practice Research Datalink (CPRD).4 CPRD is a 43 
routinely collected primary care database in the United Kingdom (UK) covering 44 
approximately 7% of the UK population.4 CPRD has been linked to the Hospital Episode 45 
Statistics (HES), a secondary healthcare administrative database in England, and is 46 
broadly representative of the general UK population regarding age, gender and life-style 47 
related factors.4,5  48 
We defined a child as having eczema if he/she had one diagnostic code for eczema with 49 
at least two eczema-related treatment codes on separate days within three months 50 
before or one year after the eczema diagnosis (see Online Repository, for additional 51 
details). The earliest date of an eczema diagnosis was defined as the incidence date. 52 
Previous research6 has shown that the combination of one eczema diagnostic code with 53 
two eczema-related treatment codes on separate days at any time gives a 90% (95% 54 
confidence interval (95%CI) 83-96%) positive predictive value for identifying prevalent 55 
eczema in children. We excluded children registered with their current primary care 56 
practice after three months of birth or children with a history of eczema before the start 57 
of the study to minimise the risk of misclassifying recurrent eczema events as first 58 
events (see Figure E1, Online Repository, for additional details). 59 
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We calculated incidence rates per 100 person-years and adjusted rate ratios (aRR) for 60 
age (< 1 year old, 1-4 years old, 5-17 years old), gender, socioeconomic status (defined 61 
as quintiles of the patient-level English Index of Multiple Deprivation7), and ethnicity 62 
(when available) using Poisson regression modelling with mutual adjustment (see Table 63 
1). Since people with different socio-demographic characteristics could have different 64 
health seeking behaviours, we also adjusted for the number of annual consultations in 65 
the study follow-up period to minimise potential ascertainment bias. We also examined 66 
the incidence rate and aRR for calendar year adjusted for age, gender and socioeconomic 67 
status. We examined whether there was evidence of statistical interaction between age 68 
and gender, socioeconomic status and ethnicity using the likelihood ratio test (p<0.05). 69 
Since the quality of ethnicity recording in the HES-linked CPRD population is only 70 
comparable to the UK population for people registered after 20068, for any analysis using 71 
ethnicity data we excluded children registered before 1st April 2006 and conducted a 72 
complete case analysis. To test the robustness of our results, we conducted four 73 
sensitivity analyses (Online Repository). The study protocol was approved by the 74 
Independent Scientific Advisory Committee (Protocol No: 16_056) and published here: 75 
https://www.cprd.com/isac/Protocol_16_056.asp. 76 
The study population consisted of 675,087 children of which 98,082 (14.5%) had a first 77 
clinical diagnosis of eczema. Compared to children without eczema, children with eczema 78 
had a slightly longer follow-up period and a higher annual consultation rate (Table E1, 79 
Online Repository). 80 
The incidence rate by calendar year remained stable in 1997-2015 (Figure E2, Online 81 
Repository) and the aRR for each additional calendar year was 1.0 (95%CI 1.0-1.0). The 82 
incidence rate of eczema was highest in the first year of life (13.8 per 100 person-years, 83 
95%CI 13.7-13.9) and decreased substantially afterwards (Figure 1). We found 84 
statistically significant interaction between age and other sociodemographic factors 85 
(p<0.001). There was a 30% higher incidence rate in boys than in girls in children <1 86 
year old (aRR=1.3, 95%CI 1.3-1.4) and a 20% lower rate in boys than in girls for 87 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
6 
 
children ≥5 years old (aRR=0.8, 95%CI 0.7-0.8) (Table 1). Comparing the incidence 88 
rate in children of the lowest socioeconomic status, children of the highest socioeconomic 89 
status had a 20% higher incidence rate in the younger age groups (aRR=1.2, 95%CI 90 
1.2-1.3 in <1 year old and 1.2, 1.1-1.3 in 1-4 years old); such difference however was 91 
not observed in children ≥5 years old (Table 1). Moreover, the incidence of clinically 92 
diagnosed eczema in the first year of life was 2 to 3-fold higher in Chinese children 93 
(aRR=3.4, 95%CI 3.0-3.8), Bangladeshi children (aRR=2.5, 95%CI 2.3-2.8) and Black 94 
Caribbean children (aRR=2.5, 95%CI 2.3-2.9) compared to white children (Table 1). The 95 
incidence decreased by age for all ethnic groups but generally remained higher in non-96 
white children than white children (Table E2, Online Repository). Results from the 97 
sensitivity analyses were all similar compared to the main analysis (see Tables E3, E4 98 
and E5, Online Repository). 99 
Our study shows that the incidence of eczema varies substantially by age and is highest 100 
in the first year of life, especially in boys, Chinese, Bangladeshi and Black Caribbean 101 
children and children of high socioeconomic status. The study confirms the previously 102 
reported link between high socioeconomic status and the occurrence of eczema,9 and 103 
also reports novel findings on ethnic group and gender differences. The former could be 104 
due to different environmental risk factors such as diet, living conditions at home or 105 
decreased exposure to ultraviolet light.E1-E3 The latter may be potentially due to different 106 
immune responses of boys and girls in early childhood,E4 but different environment 107 
exposures such as differing exposures to soap/shampoo productsE5 at older age . 108 
The main strength of our study is the large sample size, which has allowed us to 109 
examine interactions with age. A potential limitation is ascertainment bias but we have 110 
tried to minimise this by adjusting for the number of annual consultations during the 111 
study follow-up period in all the analyses. 112 
In conclusion, our findings highlight the early onset of eczema in children, with higher 113 
incidence found in boys, Chinese, Bangladeshi and Black Caribbean children, and those 114 
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with high socio-economic status. With new prevention approaches potentially availableE6 115 
and early intervention trials currently underway,E7 our study may help policy makers 116 
identify high risk children and better allocate limited healthcare resources.117 
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Figure Legends 
 
Figure 1 Incidence rate (per 100 person-years) of eczema by age and sex, N=675,087 (dotted lines showing 95% confidence intervals)
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Table 1 Incidence rates and rate ratios of eczema by different sociodemographic factors stratified by age (N=675,087) 
 
 < 1 year old  1-4 years old 5-17 years 
n of eczema=55,525 n of eczema=34,729 n of eczema=7,828 
Rate* (95% CI) aRR$ (95% CI) Rate* (95% CI) aRR$ (95% CI) Rate* (95% CI) aRR$ (95% CI) 
Sex       
 Male 15.9 (15.7-16.1) 1.3 (1.3-1.4)£ 2.9 (2.9-3.0) 0.9 (0.9-1.0) 0.4 (0.3-0.4) 0.8 (0.7-0.8)£ 
 Female 11.7 (11.5-11.8) Reference 3.0 (2.9-3.0) Reference 0.5 (0.5-0.5) Reference 
Index of Multiple Deprivation       
 1 (least deprived) 15.5 (15.3-15.8) 1.2 (1.2-1.3)£ 3.2 (3.2-3.3) 1.2 (1.1-1.3)£ 0.4 (0.4-0.4) 1.0 (0.9-1.1) 
 2 13.7 (13.5-14.0) 1.1 (1.0-1.1) 3.0 (2.9-3.1) 1.1 (1.0-1.1) 0.4 (0.4-0.4) 1.0 (0.9-1.1) 
 3 13.5 (13.3-13.8) 1.0 (1.0-1.1) 2.9 (2.8-3.0) 1.0 (0.9-1.1) 0.4 (0.4-0.4) 1.0 (0.9-1.1) 
 4 13.1 (12.8-13.3) 1.0 (1.0-1.1) 2.8 (2.8-2.9) 1.0 (0.9-1.1) 0.4 (0.4-0.5) 1.0 (1.0-1.1) 
 5 (most deprived) 12.9 (12.6-13.2) Reference 2.8 (2.7-2.9) Reference 0.4 (0.4-0.5) Reference 
Ethnicity**  n of eczema=25,593   n of eczema=12,862 n of eczema=391 
 White 12.4 (12.2-12.6) Reference 3.3 (3.2-3.3) Reference 0.5 (0.4-0.5) Reference 
 Black Caribbean 28.8 (25.6-32.4) 2.5 (2.3-2.9)£ 5.4 (4.5-6.6) 2.0 (1.6-2.4)£ 1.5 (0.6-4.0) 3.5 (1.3-9.3)£ 
 Bangladeshi 30.4 (27.2-34.1) 2.5 (2.3-2.8)£ 5.3 (4.3-6.5) 1.4 (1.1-1.7)£ 1.0 (0.3-3.0) 1.6 (0.5-5.1) 
 Chinese 41.7 (36.9-47.2) 3.4 (3.0-3.8)£ 4.6 (3.4-6.2) 1.6 (1.2-2.2)£ 0.7 (0.1-5.1) 1.9 (0.3-13.3) 
 All other ethnic groups combined& 20.8 (20.2-21.4) 1.7 (1.6-1.8)£ 3.9 (3.8-4.1) 1.1 (1.0-1.2) 1.0 (0.8-1.2) 1.9 (1.5-2.5)£ 
aRR=adjusted rate ratio 
95% CI=95% confidence interval 
*Rate per 100 person-years 
**Restricted to children with current registration dates on or after April 1st 2006 (N=303,327 of which 48,301 with eczema) and a 
complete case analysis was conducted first by excluding 55,529 (18.3%) children with missing ethnicity (N=247,798) 
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$For sex, model adjusted for Index of Multiple Deprivation and the number of annual consultations during the study follow-up period; for 
Index of Multiple Deprivation, model adjusted for sex and the number of annual consultations during the study follow-up period; for 
ethnicity (only available for children registered after 2006), model adjusted for sex, Index of Multiple Deprivation and the number of 
annual consultations during the study follow-up period 
£p<0.05 
&including mixed, black African, black other, Indian, Pakistani, Asian other and other children (e.g. Egyptian)  
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Supplementary Methods 1 
Defining eczema 2 
Diagnoses in the CPRD are coded using the Read code system, which is based on a 3 
hierarchal clinical classification system and can be cross referenced to the International 4 
Classification of Disease (ICD).E8 We defined a child as having eczema if he/she had one 5 
diagnostic code for eczema (Read codes M111.00 Atopic dermatitis/eczema, M112.00 6 
Infantile eczema, M113.00 Flexural eczema, M114.00 Allergic intrinsic eczema, M12z100 7 
Eczema NOS) with at least two eczema-related treatment codes on separate days within 8 
three months before or one year after the diagnosis. The following eczema-related 9 
treatments were used: prescriptions of emollients, topical steroids, topical calcineurin 10 
inhibitors (including pimecrolimus and tacrolimus), systemic steroids, systemic 11 
immunomodulatory agents (including methotrexate, cyclosporine, azathioprine and 12 
mycophenolate mofetil) and ultraviolet light therapy. Drug prescriptions were identified 13 
from the CPRD using drug codes based on the British National Formulary chapters. 14 
Ultraviolet light therapy treatments were identified from both the CPRD and HES using 15 
Read and OPCS4 codes, respectively. 16 
Sensitivity analyses 17 
To test the robustness of our results, we conducted four sensitivity analyses and 18 
compared the results to the main analysis. 19 
1. Missing ethnicity data: Since 18.3% children had missing information on ethnicity, we 20 
used multiple imputation to replace missing values for ethnicity by using multinomial 21 
logistic regression and created 10 imputed datasets. We combined estimates using 22 
Rubin’s rule to obtain final estimates and compared the results to the complete case 23 
analysis.  24 
2. More inclusive eczema definition: We defined a child as having eczema if he/she had 25 
one diagnostic code for eczema with at least one eczema-related treatment within three 26 
months before or after the eczema diagnosis.  27 
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3. More restrictive eczema definition for the first year of life: To minimise the potential 28 
misclassification of eczema diagnosis in the first year of life, we defined a child as having 29 
eczema in the first year if he/she had eczema in the first year and prescribed any 30 
eczema-related treatment in the second year of life also.  31 
4. Alternative study population: As we excluded a large proportion of children, i.e. those 32 
registered with their current primary care physician after the first three months of birth 33 
(1,097,638 out of 1,838,877; 59.7%), our study population could be less representative 34 
of the general paediatric population. Therefore we re-ran our analysis on the total 35 
population identified from the HES-linked CPRD. For this sensitivity analysis, to ensure 36 
we only included incident diagnoses and not prevalent ones in children registered after 37 
the first year of life, we excluded the first 12 months after the current registration date 38 
and children whose first eczema diagnosis was within this first 12 months period were 39 
also excluded.  40 
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Table E1 Characteristic of children without and with eczema (N=675,087) 
 Children without eczema Children with eczema 
 n=577,005 n=98,082 
 n (%) n (%) 
Age at registration with current GP 
months, median (IQR) 
0.77 (0.20-1.40) 0.80 (0.37-1.33) 
Age at start of prospective follow-up 
months, median (IQR) 
1.30 (0.63-16.67) 0.90 (0.47-1.57) 
Average length of prospective follow-up 
months, median (IQR) 
54.73 (20.22-112.00) 74.27 (37.53-125.93) 
Sex, male 293,828 (50.92) 53,124 (54.16)£ 
Index of Multiple Deprivation   
  1 (Least deprived) 123,060 (21.33) 24,334 (24.81)£ 
  2 120,913 (20.96) 20,646 (21.05) 
  3 110,121 (19.08) 18,019 (18.37) 
  4 117,033 (20.28) 18,442 (18.80) 
  5 (most deprived) 105,878 (18.35) 16,641 (16.97) 
Ethnicity* n=255,026 n=48,301 
  White 176,964 (84.69) 30,761 (79.19)£ 
  Mixed      7,824 (3.74)     1,604 (4.13) 
  Black Caribbean      1,094 (0.52)        378 (0.97) 
  Black African      4,779 (2.29)     1,172 (3.02) 
  Black Other      1,030 (0.49)        323 (0.83) 
  Indian      4,560 (2.18)     1,319 (3.40) 
  Bangladeshi      1,084 (0.52)        396 (1.02) 
  Pakistani      4,265 (2.04)     1,114 (2.87) 
  Chinese         704 (0.34)        294 (0.76) 
  Asian Other      2,961 (1.42)        790 (2.03) 
  Other      3,687 (1.76)        695 (1.79) 
  Missing              46,074               9,455 
Annual consultation rate$, median (IQR) 3.50 (1.84-6.36) 10.29 (5.92-16.23)£ 
IQR=interquartile range 
*Restricted to children with current registration dates on or after April 1st 2006 (N=303,327 of 
which 48,301 with eczema) and a complete case analysis was conducted first by excluding 55,529 
(18.3%) children with missing ethnicity (N=247,798) 
$Number of consultations per year during the study follow-up period  
£p<0.05 
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Table E2 Incidence rates and rate ratios of eczema by ethnicity stratified by age (N=247,798 with complete data on ethnicity) 
Ethnicity < 1 year old  1-4 years old 5-17 years old 
n of eczema=25,593 n of eczema=12,862 n of eczema=391 
Rate* (95% CI) aRR$ (95% CI) Rate* (95% CI) aRR$ (95% CI) Rate* (95% CI) aRR$ (95% CI) 
  White 12.4 (12.2-12.6) Reference 3.3 (3.2-3.3) Reference 0.5 (0.4-0.5) Reference 
  Mixed 17.7 (16.7-18.8) 1.5 (1.4-1.6) 3.7 (3.3-4.0) 1.1 (1.0-1.3) 0.6 (0.3-1.0) 1.2 (0.7-2.3) 
  Black Caribbean 28.8 (25.6-32.4) 2.6 (2.3-2.9)& 5.4 (4.5-6.6) 2.0 (1.6-2.4) 1.5 (0.6-4.0) 3.5 (1.3-9.4)& 
  Black African 22.3 (20.8-23.8) 2.0 (1.8-2.1) 3.9 (3.5-4.4) 1.3 (1.2-1.5) 1.1 (0.6-1.9) 2.6 (1.5-4.5) 
  Black Other 29.6 (26.1-33.5) 2.6 (2.3-3.0) 4.0 (3.1-5.1) 1.4 (1.1-1.8) 2.4 (1.2-4.8) 5.8 (2.8-11.8) 
  Indian 24.3 (22.9-25.9) 1.8 (1.6-2.0) 4.2 (3.7-4.6) 1.2 (1.1-1.4) 0.9 (0.6-1.6) 1.8 (1.1-3.1) 
  Bangladeshi 30.4 (27.2-34.1) 2.5 (2.3-2.8) 5.3 (4.3-6.5) 1.4 (1.1-1.7) 1.0 (0.3-3.0) 1.6 (0.5-5.1) 
  Pakistani 20.6 (19.2-22.1) 1.7 (1.5-1.9) 4.1 (3.7-4.6) 0.7 (0.5-1.2) 0.8 (0.5-1.4) 1.4 (0.8-2.5) 
  Chinese 41.7 (36.9-47.2) 3.4 (3.0-3.8) 4.6 (3.4-6.2) 1.6 (1.2-2.2) 0.7 (0.1-5.1) 1.9 (0.3-13.3) 
  Asian Other 23.6 (21.8-25.6) 2.0 (1.8-2.1) 4.4 (3.8-5.1) 1.2 (1.1-1.4) 1.8 (1.0-3.3) 3.3 (1.8-6.1) 
  Other (e.g. Egyptian) 16.4 (15.0-17.9) 1.3 (1.1-1.5) 3.6 (3.1-4.2) 1.2 (1.0-1.4) 0.7 (0.3-1.8) 1.6 (0.6-3.8) 
aRR=adjusted rate ratio 
95% CI=95% confidence interval 
*Rate per 100 person-years 
$Model adjusted for sex, Index of Multiple Deprivation and the number of annual consultations during the study follow-up period  
&compared to Table 1 these estimates changed slightly due to a different number of covariates included in the regression model
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Table E3 Results after using a more inclusive eczema definition: Incidence rates and rate ratios of eczema by sociodemographic factors 
stratified by age (N=675,087 for analysis on sex and Index of Multiple Deprivation and N=247,798 for analysis on ethnicity) 
 < 1 year old  1-4 years old 5-17 years old 
n of eczema=70,425 n of eczema=57,809 n of eczema=18,247 
Rate* (95% CI) aRR$ (95% CI) Rate* (95% CI) aRR$ (95% CI) Rate* (95% CI) aRR$ (95% CI) 
Sex       
 Male 20.3 (20.1-20.5) 1.3 (1.3-1.3) 5.3 (5.2-5.3) 1.0 (0.9-1.0) 0.9 (0.9-0.9) 0.7 (0.7-0.8) 
 Female 15.3 (15.1-15.5) Reference 5.4 (5.4-5.4) Reference 1.2 (1.2-1.3) Reference 
Index of Multiple Deprivation       
 1 (least deprived) 20.0 (19.7-20.3) 1.2 (1.2-1.2) 5.9 (5.8-6.0) 1.1 (1.1-1.2) 1.1 (1.1-1.1) 1.0 (1.0-1.1) 
 2 17.8 (17.5-18.1) 1.1 (1.1-1.1) 5.4 (5.3-5.5) 1.1 (1.1-1.1) 1.1 (1.0-1.1) 1.0 (1.0-1.1) 
 3 17.5 (17.2-17.8) 1.1 (1.0-1.1) 5.2 (5.1-5.3) 1.1 (1.0-1.1) 1.1 (1.0-1.1) 1.0 (1.0-1.1) 
 4 16.9 (16.6-17.2) 1.0 (1.0-1.1) 5.0 (4.9-5.1) 1.0 (1.0-1.1) 1.0 (1.0-1.1) 1.0 (0.9-1.0) 
 5 (most deprived) 16.5 (16.2-16.8) Reference 4.9 (4.8-5.0) Reference 1.1 (1.0-1.1) Reference 
Ethnicity  n of eczema=32,215   n of eczema=20,476 n of eczema=893 
  White 16.2 (16.0-16.4) Reference 5.7 (5.6-5.8) Reference 1.3 (1.2-1.3) Reference 
  Mixed 22.1 (21.0-23.3) 1.4 (1.3-1.5) 6.0 (5.6-6.5) 1.1 (1.0-1.2) 1.5 (1.0-2.2) 1.2 (0.8-1.8) 
  Black Caribbean 33.6 (30.1-37.5) 2.3 (2.0-2.5) 7.1 (6.0-8.5) 1.3 (1.1-1.6) 2.4 (1.1-5.3) 2.0 (0.9-4.6) 
  Black African 26.2 (24.6-27.9) 1.8 (1.7-1.9) 5.5 (5.0-6.1) 1.0 (0.9-1.1) 1.8 (1.2-2.8) 1.4 (0.9-2.3) 
  Black Other 33.1 (29.5-37.3) 2.2 (2.0-2.5) 5.7 (4.6-7.0) 1.1 (0.9-1.3) 3.9 (2.2-6.9) 3.5 (2.0-6.3) 
  Indian 28.8 (27.1-30.5) 1.7 (1.5-1.8) 6.4 (5.9-7.0) 1.1 (1.0-1.2) 1.5 (1.0-2.4) 1.1 (0.7-1.8) 
  Bangladeshi 34.1 (30.6-38.0) 2.2 (1.9-2.4) 7.8 (6.5-9.2) 1.3 (1.1-1.6) 3.4 (1.7-6.4) 2.3 (1.2-4.5) 
  Pakistani 23.5 (22.0-25.1) 1.5 (1.4-1.6) 5.9 (5.4-6.5) 1.0 (0.9-1.1) 1.8 (1.2-2.7) 1.3 (0.9-2.0) 
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  Chinese 51.0 (45.5-57.1) 3.1 (2.8-3.5) 7.6 (5.9-9.7) 1.4 (1.1-1.8) 0.8 (0.1-6.0) 0.8 (0.1-5.5) 
  Asian Other 28.0 (26.0-30.2) 1.8 (1.6-1.9) 6.2 (5.5-7.1) 1.1 (1.0-1.2) 2.5 (1.5-4.2) 1.9 (1.1-3.2) 
  Other 21.2 (19.6-22.9) 1.3 (1.1-1.4) 5.7 (5.1-6.4) 1.0 (0.9-1.2) 1.8 (1.0-3.2) 1.5 (0.8-2.6) 
aRR=adjusted rate ratio 
95% CI=95% confidence interval 
*Rate per 100 person-years 
$Model adjusted for sex, Index of Multiple Deprivation and the number of annual consultations during the study follow-up period 
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Table E4 Results after using a more strict eczema definition for the first year of life: Incidence rates and rate ratios of eczema by 
sociodemographic factors stratified by age (N=675,087 for analysis on sex and Index of Multiple Deprivation and N=247,798 for analysis 
on ethnicity) 
 < 1 year old  1-4 years old 5-17 years old 
n of eczema=39,579 n of eczema=34,729 n of eczema=7,828 
Rate* (95% CI) aRR$ (95% CI) Rate* (95% I) aRR$ (95% CI) Rate* (95% CI) aRR$ (95% CI) 
Sex       
 Male 11.0 (10.9-11.2) 1.3 (1.3-1.3) 2.9 (2.8-2.9) 1.0 (0.9-1.0) 0.4 (0.3-0.4) 0.7 (0.7-0.9) 
 Female 8.2 (8.1-8.3) Reference 2.9 (2.9-3.0) Reference 0.5 (0.5-0.5) Reference 
Index of Multiple Deprivation       
 1 (least deprived) 11.2 (11.0-11.4) 1.3 (1.2-1.4) 3.1 (3.1-3.2) 1.2 (1.1-1.2) 0.4 (0.4-0.4) 0.9 (0.9-1.0) 
 2 9.7 (9.5-9.9) 1.1 (1.1-1.2) 2.9 (2.9-3.0) 1.1 (1.0-1.1) 0.4 (0.4-0.4) 0.9 (0.9-1.0) 
 3 9.4 (9.2-9.6) 1.0 (0.9-1.1) 2.8 (2.7-2.9) 1.0 (1.0-1.0) 0.4 (0.4-0.4) 0.9 (0.9-1.0) 
 4 8.9 (8.7-9.1) 1.1 (1.0-1.1) 2.8 (2.7-2.8) 1.0 (1.0-1.1) 0.4 (0.4-0.4) 1.0 (0.9-1.1) 
 5 (most deprived) 8.7 (8.5-8.9) Reference 2.7 (2.6-2.8) Reference 0.4 (0.4-0.5) Reference 
Ethnicity n of eczema=18,583   n of eczema=12,862 n of eczema=391 
  White 8.6 (8.4-8.7) Reference 3.2 (3.1-3.2) Reference 0.4 (0.4-0.5) Reference 
  Mixed 11.9 (11.2-12.8) 1.4 (1.3-1.5) 3.5 (3.2-3.9) 1.1 (1.0-1.2) 0.5 (0.3-1.0) 1.2 (0.6-2.3) 
  Black Caribbean 20.6 (18.0-23.6) 2.7 (2.4-3.1) 5.3 (4.3-6.4) 1.8 (1.4-2.2) 1.5 (0.6-3.9) 3.2 (1.2-8.7) 
  Black African 15.3 (14.1-16.6) 2.0 (1.8-2.2) 3.8 (3.4-4.3) 1.3 (1.1-1.4) 1.1 (0.6-1.8) 2.3 (1.3-4.1) 
  Black Other 18.6 (16.0-21.7) 2.4 (2.1-2.8) 3.8 (3.0-4.9) 1.3 (1.0-1.6) 2.4 (1.2-4.7) 5.2 (2.5-10.5) 
  Indian 17.3 (16.0-18.6) 1.7 (1.3-2.3) 4.0 (3.6-4.4) 1.3 (1.1-1.4) 0.9 (0.5-1.5) 2.0 (1.2-3.4) 
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  Bangladeshi 23.4 (20.6-26.5) 2.9 (2.6-3.3) 5.1 (4.1-6.2) 1.6 (1.3-2.0) 0.9 (0.3-2.9) 2.0 (0.6-6.1) 
  Pakistani 14.1 (13.0-15.3) 1.8 (1.6-1.9) 4.0 (3.5-4.4) 1.3 (1.1-1.4) 0.8 (0.4-1.4) 1.7 (0.9-3.0) 
  Chinese 24.4 (20.9-28.5) 2.8 (2.4-3.3) 4.2 (3.1-5.7) 1.3 (1.0-1.8) 0.7 (0.1-4.6) 1.5 (0.2-10.5) 
  Asian Other 15.1 (13.7-16.7) 1.8 (1.6-2.0) 4.2 (3.6-4.8) 1.3 (1.1-1.5) 1.7 (0.9-3.1) 3.7 (2.0-6.8) 
  Other 9.9 (8.8-11.0) 1.2 (1.1-1.4) 3.4 (3.0-4.0) 1.1 (1.0-1.3) 0.7 (0.3-1.7) 1.5 (0.6-3.7) 
aRR=adjusted rate ratio 
95% CI=95% confidence interval 
*Rate per 100 person-years 
$Model adjusted for sex, Index of Multiple Deprivation and the number of annual consultations during the study follow-up period 
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Table E5 Results in the overall child population regardless of the GP registration date related to birth: Incidence rates and rate ratios of 
eczema by sociodemographic factors stratified by age (N=1,472,337 for analysis on sex and Index of Multiple Deprivation and 
N=392,830 for analysis on ethnicity) 
 < 1 year old  1-4 years old 5-17 years old 
n of eczema=59,840 n of eczema=44,111 n of eczema=22,527 
Rate* (95% CI) aRR$ (95% CI) Rate* (95% I) aRR$ (95% CI) Rate* (95% CI) aRR$ (95% CI) 
Sex       
 Male 15.9 (15.7-16.1) 1.3 (1.3-1.4) 2.8 (2.8-2.9) 1.0 (1.0-1.0) 0.4 (0.4-0.4) 0.7 (0.7-0.7) 
 Female 11.7 (11.6-11.8) Reference 2.9 (2.8-2.9) Reference 0.5 (0.5-0.5) Reference 
Index of Multiple Deprivation       
 1 (least deprived) 15.6 (15.4-15.9) 1.2 (1.2-1.3) 3.1 (3.1-3.2) 1.3 (1.2-1.3) 0.4 (0.4-0.4) 0.9 (0.9-1.0) 
 2 13.8 (13.5-14.0) 1.1 (1.0-1.1) 2.9 (2.8-2.9) 1.2 (1.1-1.2) 0.4 (0.4-0.4) 0.9 (0.9-0.9) 
 3 13.6 (13.3-13.8) 1.1 (1.0-1.1) 2.8 (2.7-2.9) 1.1 (1.1-1.2) 0.4 (0.4-0.5) 0.9 (0.9-1.0) 
 4 13.1 (12.9-13.3) 1.0 (1.0-1.1) 2.7 (2.7-2.8) 1.1 (1.1-1.1) 0.5 (0.5-0.5) 1.0 (1.0-1.0) 
 5 (most deprived) 12.9 (12.6-13.1) Reference 2.7 (2.6-2.7) Reference 0.5 (0.5-0.5) Reference 
Ethnicity n of eczema=26,958   n of eczema=15,269 n of eczema=1,824 
  White 12.4 (12.2-12.5) Reference 3.1 (3.1-3.2) Reference 0.5 (0.5-0.5) Reference 
  Mixed 17.8 (16.8-18.8) 1.5 (1.4-1.6) 3.6 (3.3-3.9) 1.2 (1.1-1.4) 0.7 (0.5-0.9) 1.4 (1.0-1.9) 
  Black Caribbean 28.6 (25.5-32.0) 2.5 (2.3-2.8) 5.3 (4.4-6.4) 2.1 (1.7-2.5) 1.7 (1.1-2.5) 3.5 (2.4-5.2) 
  Black African 21.9 (20.6-23.4) 1.9 (1.8-2.1) 3.9 (3.5-4.3) 1.5 (1.3-1.6) 1.0 (0.8-1.2) 2.1 (1.7-2.6) 
  Black Other 28.5 (25.2-32.2) 2.5 (2.2-2.8) 3.9 (3.2-4.9) 1.4 (1.1-1.8) 1.8 (1.3-2.5) 3.7 (2.6-5.3) 
  Indian 24.1 (22.7-25.6) 1.9 (1.7-2.0) 4.0 (3.7-4.4) 1.3 (1.2-1.4) 1.0 (0.9-1.3) 2.2 (1.8-2.7) 
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  Bangladeshi 31.2 (28.0-34.8) 2.4 (2.1-2.9) 5.3 (4.4-6.3) 1.6 (1.3-1.9) 1.2 (0.7-2.1) 2.3 (1.3-4.0) 
  Pakistani 20.1 (18.7-21.5) 1.6 (1.5-1.8) 3.8 (3.5-4.2) 1.1 (0.9-1.3) 1.0 (0.8-1.2) 1.8 (1.5-2.3) 
  Chinese 41.8 (37.1-41.1) 3.4 (3.0-3.8) 4.6 (3.5-5.9) 1.7 (1.3-2.2) 0.5 (0.2-1.6) 1.1 (0.3-3.3) 
  Asian Other 23.6 (21.8-25.5) 2.0 (1.8-2.1) 4.3 (3.8-4.9) 1.3 (1.2-1.5) 1.2 (0.8-1.6) 2.3 (1.6-3.2) 
  Other 16.7 (15.4-18.2) 1.3 (1.2-1.5) 3.2 (2.8-3.6) 1.1 (1.0-1.3) 0.9 (0.7-1.2) 1.9 (1.4-2.6) 
aRR=adjusted rate ratio 
95% CI=95% confidence interval 
*Rate per 100 person-years 
$Model adjusted for sex, Index of Multiple Deprivation and the number of annual consultations during the study follow-up period 
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Figure E1 Constructing the final study population (N=675,087) 
Children aged 0-17 years between April 1997 and 
March 2015 from HES linked CPRD (N=1,838,877) 
Children registered with current general practice within 
3 months after birth (N=731,239) 
Final study population (N=675,087) 
The following types of children with a history of 
eczema before the start of the follow-up period were 
excluded: 
• At least one of the five Read codes for eczema 
before the start of follow-up (n=45,938) 
• Eczema inpatient diagnosis as first recording of 
eczema (n=656) 
• Eczema history code (i.e. H/O: eczema) as 
first recording of eczema (n=7,569) 
Children without eczema at the start of the follow-up period 
(N=677,076) 
Children with missing information on socioeconomic 
status were excluded (n=1,989) 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Figure E2 Incidence rate (per 100 person-years) of eczema by calendar year, N=675,087 
